Form 4: Medicine Man Technologies Director Acquires Shares as Compensation
SEC Form 4 Filing
Marc R. Rubin, a director of Medicine Man Technologies, acquired 67,308 shares of common stock as compensation for board service.
Summary
- On June 28, 2024, Marc R. Rubin, a director of Medicine Man Technologies, acquired 67,308 shares of common stock.
- The shares were granted as compensation for service on the board of directors.
- The aggregate value of the shares was $26,250, based on the closing price of the common stock on the OTCQX Best Market on June 28, 2024.
- Following the transaction, Rubin directly owns 244,776 shares of common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects a standard compensation practice, indicating alignment between the director and the company's shareholders. There are no red flags or negative implications.
Positives
- The acquisition of shares by a director demonstrates alignment with shareholder interests.
- The compensation structure incentivizes board members to contribute to the company's success.
Industry Context
This type of transaction is common for directors of publicly traded companies, where stock grants are used as part of their compensation packages to align their interests with those of shareholders. It's a standard practice in the industry to incentivize board members.
Comparison to Industry Standards
- Stock grants to directors are a common practice across various industries, particularly in publicly traded companies.
- Companies like Canopy Growth Corporation and Aurora Cannabis also use stock options and grants as part of their director compensation packages.
- The size of the grant, valued at $26,250, appears to be within the typical range for smaller companies listed on the OTCQX market.
Stakeholder Impact
- Shareholders may view this positively as it aligns the director's interests with the company's performance.
- Employees may see this as a sign of stability and commitment from the board.
Key Dates
| Date | Description |
|---|---|
| 06/28/2024 | Date of transaction: Marc R. Rubin acquired 67,308 shares of common stock. |
| 07/02/2024 | Date of signature: Form 4 signed by Christine Jones, attorney-in-fact for Marc R. Rubin. |
Keywords
Medicine Man Technologies, SHWZ, Form 4, Director, Share Acquisition, Marc R. Rubin, Compensation, OTCQX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.